K279-1006 Screening compound: N~1~-CYCLOHEXYL-3-[5-({2-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

K279-1006 Screening compound: N~1~-CYCLOHEXYL-3-[5-({2-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE
K279-1006 Screening compound: N~1~-CYCLOHEXYL-3-[5-({2-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1006
N~1~-CYCLOHEXYL-3-[5-({2-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1006

Molecular Formula

C25H29N7O3S (C25 H29 N7 O3 S)

Compound Name

N~1~-CYCLOHEXYL-3-[5-({2-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]PROPANAMIDE

IUPAC name

n/a

SMILES

Cc1cc(NC(CSC(N2C3CCC(NC4CCCCC4)=O)=Nc(cccc4)c4C2=NC3=O)=O)n[nH]1

InChI

InChI=1S/C25H29N7O3S/c1-15-13-20(31-30-15)28-22(34)14-36-25-27-18-10-6-5-9-17(18)23-29-24(35)19(32(23)25)11-12-21(33)26-16-7-3-2-4-8-16/h5-6,9-10,13,16,19H,2-4,7-8,11-12,14H2,1H3,(H,26,33)(H2,28,30,31,34)/t19-/m0/s1

InChI Key

IGJGGWUZAGBJOM-IBGZPJMESA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

507.62

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.385

Distribution Coefficient, logD

2.383

Water Solubility, LogSw

-3.07

Polar Surface Area

105.633

Acid Dissociation Constant (pKa)

9.77

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

K279-1006 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K279-1006 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1006?
Check Price and Availability of K279-1006, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1006 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1006
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1006
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1006 available by request